Keywords: دیسکینزی; Botulinum toxin; Parkinsonism; Parkinson's disease; Atypical parkinsonism; Sialorrhea; Dyskinesias; Pain; Freezing of gait; Camptocormia;
مقالات ISI دیسکینزی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیسکینزی; Parkinson's disease; Dyskinesias; Dopamine Dysregulation Syndrome; DDS; Impulse control disorders; ICD; Hallucinations; Depression; Motor subtypes;
Keywords: دیسکینزی; Parkinson's disease; Dyskinesias; Self-awareness; Theory of Mind; Reading the Mind in the Eyes;
Keywords: دیسکینزی; Myelinolysis; Osmotic demyelination; Tremor; Parkinsonism; Dyskinesias; Levodopa;
Keywords: دیسکینزی; Somatosensory cortex; Single neuronal activity; Parkinson's disease; Dyskinesias;
Keywords: دیسکینزی; Catatonia; Dyskinesias; First-episode psychosis; Movement abnormalities; Schizophrenia; Stereotypies;
Keywords: دیسکینزی; Parkinson's disease; Device-aided therapies; Motor fluctuations; Dyskinesias; Non-motor symptoms;
Keywords: دیسکینزی; Parkinson's disease; Aging; Rodent; Grafting; Dyskinesias; Levodopa; Synaptopodin
Keywords: دیسکینزی; Physical Therapy Modalities; Posture; Muscle Stretching Exercises; Dyskinesias; Neck Pain;
Keywords: دیسکینزی; Awareness of movement disorders; Dyskinesias; Parkinson’s disease; Self-awareness; Metacognitive functions
Keywords: دیسکینزی; Parkinson disease; Dyskinesias; Aanosognosia;
Keywords: دیسکینزی; Parkinson's disease; Motor complications; Motor fluctuations; Dyskinesias; Risk factors
Keywords: دیسکینزی; Parkinson's disease; Dyskinesias; rTMS
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
Keywords: دیسکینزی; AAV; adeno-associated virus; ACh; acetylcholine; AIMs; abnormal involuntary movements; ANOVA; analysis of variance; LIDs; L-dopa-induced dyskinesias; ChAT; choline acetyltransferase; ChR2; channel rhodopsin 2; DAT; dopamine transporter; ERK; extracellular
Recognition and Treatment of Anti-N-Methyl-d-Aspartate Receptor Encephalitis
Keywords: دیسکینزی; anti-NMDA receptor encephalitis; seizures; dysautonomia; dyskinesias
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist
Keywords: دیسکینزی; Parkinson's disease; Glutamate; Dopamine; Movement disorders; Plasticity; Dyskinesias; Metabotropic receptor;
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population
Keywords: دیسکینزی; Parkinson's disease; COMT; MAO-B; Wearing-off; Dyskinesias;
Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats
Keywords: دیسکینزی; Parkinson's disease; Dyskinesias; Buspirone; DRD3; DARPP32 and ERK2;
Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats
Keywords: دیسکینزی; Parkinson's disease; L-dopa; Pramipexole; Dyskinesias; 6-Hydroxydopamine;
Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
Keywords: دیسکینزی; Parkinsonism; Levodopa; l-Dopa; Metabotropic glutamate antagonists; Dyskinesias;
Research reportA2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats
Keywords: دیسکینزی; A2A receptor antagonist; l-Dopa; Rat; Dyskinesias; Catalepsy;
Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
Keywords: دیسکینزی; Safinamide; Amantadine; Dyskinesias; MPTP monkey; Parkinson's disease; l-DOPA; Motor behavior;
A kinematic analysis of manual aiming control on euthymic bipolar disorder
Keywords: دیسکینزی; Movement disorders; Psychomotor performance; Dyskinesias; Basal ganglia; Bipolar disorder
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson’s disease patients
Keywords: دیسکینزی; Cerebellum; Parkinson’s disease; TMS; Dyskinesias; Levodopa
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias
Keywords: دیسکینزی; Synaptic plasticity; Dopamine; Striatum; Parkinson's disease; Dyskinesias; NMDA receptor; Cell-permeable peptides;
Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
Keywords: دیسکینزی; Glutamate receptor; mGluR5; Human; MPTP monkey; Wearing-off; Dyskinesias
Impact of omega-3 fatty acids in Parkinson's disease
Keywords: دیسکینزی; Non-motor symptoms; Alpha-synuclein; Dopaminergic system; Dyskinesias; Neuroprotection; Docosahexaenoic acid (DHA)
Choréo-acanthocytose sans acanthocytes
Keywords: دیسکینزی; Chorée; Dystonie; Acanthocytes; Neuro-acanthocytose; Choréo-acanthocytose; Chorea; Dyskinesias; Acanthocytes; Neuro-acanthocytosis; Chorea-acanthocytosis;
Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson’s disease
Keywords: دیسکینزی; Parkinsonism; fMRI; Genetics; Motor control; Dyskinesias
Quelles pistes pharmacologiques non-dopaminergiques pour le traitement de la maladie de Parkinson ?
Keywords: دیسکینزی; Maladie de Parkinson; Signes non-moteurs; Dyskinésies; Parkinson's disease; Non-motor symptoms; Dyskinesias;
Experience with continuous levodopa enteral infusion (Duodopa®)in patients with advanced Parkinson's disease in a secondary level hospital
Keywords: دیسکینزی; Dyskinesias; Duodopa; Parkinson's disease; Motor fluctuations; Continuous enteral infusion; LevodopaDiscinesias; Duodopa; Enfermedad de Parkinson; Fluctuaciones motoras; Infusión continua enteral; Levodopa
Management of Motor Complications in Parkinson Disease: Current and Emerging Therapies
Keywords: دیسکینزی; Parkinson disease; Motor complications; Motor fluctuations; Dyskinesias;
Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders
Keywords: دیسکینزی; Parkinson's disease; Pain; CM-Pf; Lateral habenula; High frequency stimulation; Dyskinesias;
Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson’s disease
Keywords: دیسکینزی; Parkinson’s disease; Dyskinesias; Motor fluctuations; Chinese, cross-sectional study
The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
Keywords: دیسکینزی; Parkinson's disease; Motor complications; Dyskinesias; Levodopa; Continuous dopaminergic stimulation
Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies
Keywords: دیسکینزی; Parkinson's disease; Basal ganglia; l-DOPA; High frequency stimulation; Subthalamic nucleus; Cytochrome oxidase; Preprodynorphin; Dyskinesias; 6-hydroxydopamine; Rat
Involvement of the serotonin system in l-dopa-induced dyskinesias
Keywords: دیسکینزی; l-Dopa; Dyskinesias; Serotonergic neurons; 5-HT1A/1B agonists; Fetal transplantation;
Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson’s disease
Keywords: دیسکینزی; Parkinson’s disease; Subthalamic nucleus; Dyskinesias; Motor cortex excitability
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias
Keywords: دیسکینزی; Basal ganglia; Parkinson's disease; Dyskinesias; mGluR2/3; NMDA antagonist; Cabergoline
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys
Keywords: دیسکینزی; Basal ganglia; Parkinson's disease; Dyskinesias; mGluR5; NMDA antagonist; Cabergoline
New strategies in motor parkinsonism
Keywords: دیسکینزی; Parkinson's disease; Motor fluctuations; Dyskinesias; Deep brain stimulation; Apomorphine; Continuous duodenal levodopa delivery
Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's Disease and dystonia
Keywords: دیسکینزی; Transcranial magnetic stimulation; Synaptic plasticity; Parkinson's disease; Dyskinesias; Dystonia; Deep brain stimulation
Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa
Keywords: دیسکینزی; Dyskinesias; l-Dopa; Parkinson's disease; Prodynorphin; Dopamine and cAMP-regulated phosphoprotein of 32Â kDa;
Mouvements anormaux paroxystiques non épileptiques de l'enfant
Keywords: دیسکینزی; Mouvements anormaux paroxystiques; Dyskinésies; Myoclonies; TicsMovement disorders; Dyskinesias; Myoclonus; Tic disorders; Child
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB1 and TRPV1 receptors
Keywords: دیسکینزی; Anandamide; Endocannabinoid; Vanilloid; Levodopa; Dyskinesias; 6-OHDA; Basal ganglia
Optimizing bioavailability in the treatment of Parkinson's disease
Keywords: دیسکینزی; Bioavailability; Parkinson's disease; Treatment; Levodopa; Dyskinesias; Adjunctive medications; Route of administration
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys
Keywords: دیسکینزی; Dyskinesias; MPTP; AADC; AAV; l-dopa; Parkinson’s disease; Monkey; Striatum; Dopamine
Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats
Keywords: دیسکینزی; Dopamine neuron grafting; Dyskinesias; Levodopa; Rats; FosB/ΔFosB transcription factors
Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on l-dopa monotherapy
Keywords: دیسکینزی; Parkinson's disease; Dyskinesias; Motor fluctuations; l-dopa; Risk factors;
Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias
Keywords: دیسکینزی; Parkinson's disease; Dyskinesias; Bradykinesia; Voluntary movement; Motor system;